Search

… Roswell Park’s Dr. Pawel Kalinski to Lead $14.5M NCI-Funded Immunotherapy Effort … 03/31/2020 - 12:00 BUFFALO, N.Y. — A team led by Pawel Kalinski, MD, PhD, of Roswell Park Comprehensive Cancer … of the most commonly prescribed immunotherapies,” says Dr. Kalinski, who is Vice Chair for Translational Research, the …

… from a U.S. Department of Defense (DoD) grant to Pawel Kalinski, MD, PhD, Vice Chair for Translational Research and … A new dendritic-cell treatment vaccine developed by Dr. Kalinski and colleagues in collaboration with Brian … using a combination proposed and validated by Dr. Kalinski as an optimized adjuvant for dendritic-cell …

… Emergent Strategies session. Dr. Kunle Odunsi Dr. Pawel Kalinski Kunle Odunsi, MD, FRCOG, FACOG, Deputy Director, … ovarian cancer during Immunotherapy Bridge 2020, and Pawel Kalinski, MD, PhD, Vice Chair for Translational Research, … Strategies session.   Dr. Kunle Odunsi   Dr. Pawel Kalinski Kunle Odunsi, MD, FRCOG, FACOG, Deputy Director, …

… increases the risk of immune-related adverse events. Pawel Kalinski, MD, PhD , Professor of Immunology at Roswell Park, … increases the risk of immune-related adverse events. Pawel Kalinski, MD, PhD , Professor of Immunology at Roswell Park, …